• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Ryan Timothy F.

    10/15/24 6:47:17 PM ET
    $CON
    Medical Specialities
    Health Care
    Get the next $CON alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    Ryan Timothy F.

    (Last) (First) (Middle)
    C/O CONCENTRA GROUP HOLDINGS PARENT,
    INC. 5080 SPECTRUM DRIVE, SUITE 1200W

    (Street)
    ADDISON TX 75001

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    10/14/2024
    3. Issuer Name and Ticker or Trading Symbol
    Concentra Group Holdings Parent, Inc. [ CON ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    See remarks.
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    Remarks:
    Executive Vice President & Chief Legal Counsel. Exhibit 24 - Power of Attorney.
    No securities are beneficially owned.
    /s/ Michael E. Tarvin, as Attorney-in-Fact 10/15/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CON alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CON

    DatePrice TargetRatingAnalyst
    12/16/2024$24.00Neutral → Buy
    BofA Securities
    10/7/2024$30.50 → $24.00Buy → Neutral
    BofA Securities
    8/20/2024$33.00Outperform
    RBC Capital Mkts
    8/19/2024Buy
    BofA Securities
    8/19/2024$29.00Buy
    Deutsche Bank
    8/19/2024$29.00Overweight
    JP Morgan
    8/19/2024$32.00Buy
    Goldman
    8/19/2024$28.00Outperform
    Mizuho
    More analyst ratings

    $CON
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Concentra® Announces Closing of Pivot Onsite Innovations Acquisition

      Concentra Group Holdings Parent, Inc. ("Concentra," "the Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services, today announced the closing of the transaction to acquire Pivot Onsite Innovations from Athletico Physical Therapy. Pivot Onsite Innovations is a leader in the onsite health industry with over 200 onsite health clinics at employer locations in over 40 states. "We are very excited about the addition of Pivot Onsite Innovations to Concentra Onsite Health," said Matt DiCanio, Concentra's President and Chief Financial Officer. "This collaboration doubles the size of our growing Concentra Onsite Health operating segment and fully al

      6/2/25 9:00:00 AM ET
      $CON
      Medical Specialities
      Health Care
    • Concentra Expands in Chattanooga, Tennessee

      Concentra® (NYSE:CON) the nation's leader in occupational medicine, today announced the opening of a new medical center in Chattanooga, Tennessee. The medical center, Concentra Chattanooga Downtown is conveniently located at 1206 Broad Street, Suite 106, Chattanooga, Tennessee 37402. "We're excited to continue our expansion in eastern Tennessee," said Janet Cobb, MD, senior vice president of Concentra medical operations. "Expanding our footprint helps us to build stronger relationships with local employers and provide employees with additional access points to care." Concentra will provide work injury care, physical therapy, drug testing, DOT physical exams, pre-placement exams, and other

      5/19/25 8:20:00 AM ET
      $CON
      Medical Specialities
      Health Care
    • Concentra Group Holdings Parent, Inc. Announces Results For Its First Quarter Ended March 31, 2025, Cash Dividend, and Revised FY 2025 Guidance

      Concentra Group Holdings Parent, Inc. ("Concentra," the "Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services, today announced results for its first quarter ended March 31, 2025, and the declaration of a cash dividend. "Concentra reported a solid start to 2025 with strong revenue and Adjusted EBITDA growth in the first quarter. With a deep understanding of patient and client needs and market dynamics, we continue to execute on key drivers of growth and deliver a comparative market advantage. Maintaining this focus ensures we continue to achieve our strategic business objectives for the year," said Keith Newton, Chief Executive Officer of

      5/7/25 4:30:00 PM ET
      $CON
      Medical Specialities
      Health Care

    $CON
    Leadership Updates

    Live Leadership Updates

    See more
    • Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

      NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE:ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions. Azenta's market capitalization is no longer representative of the mid-cap market space.Concentra Group Holdings Inc. (NYSE:CON) will replace Myers Industries Inc. (NYSE:MYE) in the S&P SmallCap 600 effective prior to the openin

      11/19/24 5:56:00 PM ET
      $AZTA
      $CON
      $ENV
      $FLEX
      Industrial Machinery/Components
      Technology
      Medical Specialities
      Health Care

    $CON
    SEC Filings

    See more
    • Concentra Group Holdings Parent Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Concentra Group Holdings Parent, Inc. (0002014596) (Filer)

      6/2/25 9:41:15 AM ET
      $CON
      Medical Specialities
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Concentra Group Holdings Parent Inc.

      SCHEDULE 13G/A - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

      5/14/25 10:45:26 AM ET
      $CON
      Medical Specialities
      Health Care
    • SEC Form 10-Q filed by Concentra Group Holdings Parent Inc.

      10-Q - Concentra Group Holdings Parent, Inc. (0002014596) (Filer)

      5/7/25 4:49:01 PM ET
      $CON
      Medical Specialities
      Health Care

    $CON
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Concentra Group Holdings Parent upgraded by BofA Securities with a new price target

      BofA Securities upgraded Concentra Group Holdings Parent from Neutral to Buy and set a new price target of $24.00

      12/16/24 6:50:31 AM ET
      $CON
      Medical Specialities
      Health Care
    • Concentra Group Holdings Parent downgraded by BofA Securities with a new price target

      BofA Securities downgraded Concentra Group Holdings Parent from Buy to Neutral and set a new price target of $24.00 from $30.50 previously

      10/7/24 7:46:54 AM ET
      $CON
      Medical Specialities
      Health Care
    • RBC Capital Mkts initiated coverage on Concentra Group Holdings Parent with a new price target

      RBC Capital Mkts initiated coverage of Concentra Group Holdings Parent with a rating of Outperform and set a new price target of $33.00

      8/20/24 6:52:13 AM ET
      $CON
      Medical Specialities
      Health Care

    $CON
    Financials

    Live finance-specific insights

    See more
    • Concentra Group Holdings Parent, Inc. Announces Results For Its First Quarter Ended March 31, 2025, Cash Dividend, and Revised FY 2025 Guidance

      Concentra Group Holdings Parent, Inc. ("Concentra," the "Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services, today announced results for its first quarter ended March 31, 2025, and the declaration of a cash dividend. "Concentra reported a solid start to 2025 with strong revenue and Adjusted EBITDA growth in the first quarter. With a deep understanding of patient and client needs and market dynamics, we continue to execute on key drivers of growth and deliver a comparative market advantage. Maintaining this focus ensures we continue to achieve our strategic business objectives for the year," said Keith Newton, Chief Executive Officer of

      5/7/25 4:30:00 PM ET
      $CON
      Medical Specialities
      Health Care
    • Concentra® Announces Signing of Definitive Agreement to Acquire Pivot Onsite Innovations

      Concentra Group Holdings Parent, Inc. ("Concentra," "the Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services, today announced the signing of a definitive agreement to acquire Pivot Onsite Innovations from Athletico Physical Therapy. Pivot Onsite Innovations is a leader in the onsite health industry with over 200 onsite health clinics at employer locations in over 40 states. "Joining forces with Pivot Onsite Innovations represents an exciting new chapter for Concentra Onsite Health," said Matt DiCanio, Concentra's President and Chief Financial Officer. "Since 1993, our onsite health clinics have provided employees with immediate access t

      4/21/25 9:00:00 AM ET
      $CON
      Medical Specialities
      Health Care
    • Concentra® to Announce First Quarter 2025 Results on Wednesday, May 7, 2025

      Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its first quarter ended March 31, 2025, on Wednesday, May 7, 2025, after the market closes. Concentra will host a conference call regarding its financial results on Thursday, May 8, 2025, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra's website at https://ir.concentra.com. A replay of the webcast will be available shortly after the call at the same locations. Participants may join the audio-only version of the webcast or participate in the question-and-answer session by calling: Toll Free: 888-5

      4/7/25 4:30:00 PM ET
      $CON
      Medical Specialities
      Health Care

    $CON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Ortenzio Robert A disposed of 3,070,367 shares and acquired 1,023,455 shares (SEC Form 4)

      4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

      3/4/25 4:59:26 PM ET
      $CON
      Medical Specialities
      Health Care
    • Officer Mcandrew Douglas R. was granted 60,000 shares (SEC Form 4)

      4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

      11/29/24 5:59:48 PM ET
      $CON
      Medical Specialities
      Health Care
    • Officer Kosuth Michael A. was granted 60,000 shares (SEC Form 4)

      4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

      11/29/24 5:58:45 PM ET
      $CON
      Medical Specialities
      Health Care

    $CON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Concentra Group Holdings Parent Inc.

      SC 13G - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

      12/9/24 6:02:26 AM ET
      $CON
      Medical Specialities
      Health Care
    • SEC Form SC 13G filed by Concentra Group Holdings Parent Inc.

      SC 13G - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

      12/6/24 4:32:57 PM ET
      $CON
      Medical Specialities
      Health Care
    • SEC Form SC 13D filed by Concentra Group Holdings Parent Inc.

      SC 13D - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

      12/3/24 4:21:17 PM ET
      $CON
      Medical Specialities
      Health Care